Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

ClinicalTrials.gov ID: NCT04511845

Public ClinicalTrials.gov record NCT04511845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 5:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of SPYK04 as Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase I, open-label, multi-center study

Study identification

NCT ID
NCT04511845
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Chugai Pharmaceutical
Industry
Enrollment
85 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2020 (Actual)
Primary completion
Jun 18, 2026 (Actual)
Completion
Jun 18, 2026 (Actual)
Last update posted
Jul 30, 2026

2020 – 2026

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Arizona Oncology Tucson Arizona 85711 —
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 —
Minnesota Oncology Minneapolis Minnesota 55404 —
Rhode Island Hospital Providence Rhode Island 02903 —
MD Anderson Cancer Center Houston Texas 77030 —
Texas Oncology Tyler Texas 75702 —
University of Virginia Charlottesville Virginia 22903 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04511845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04511845 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →